Pharmaceutical

Emergent to sell US sterile manufacturing facility to Bora

Emergent BioSolutions has agreed to divest its sterile manufacturing facility in Baltimore-Camden, Maryland, to Bora Pharmaceuticals.

Jun 22, 2024 - 04:00
Emergent to sell US sterile manufacturing facility to Bora
Emergent BioSolutions has agreed to divest its sterile manufacturing facility in Baltimore-Camden, Maryland, to Bora Pharmaceuticals.
Read the original article

Tags:

Previous Article

South Korea seeks to accelerate drug reimbursement administration process

Next Article

Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Telehealth companies that provide abortion pills grapple with regulatory uncertainty 

Telehealth companies that provide abortion pills grappl...

Apr 25, 2023

Embryo loss is integral to IVF. Alabama’s ruling equating embryos with children jeopardizes its practice

Embryo loss is integral to IVF. Alabama’s ruling equati...

Feb 23, 2024

Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder

Signal: Danaher’s $5.7bn acquisition of Abcam faces sta...

Sep 15, 2023